secwatch.observer — SEC 8-K summary
======================================

Issuer:     Replimune Group, Inc. (REPL)
CIK:        0001737953
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001104659-23-067856
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Replimune appoints Veleka Peeples-Dyer to Board of Directors, effective June 1, 2023
--------------------------------------------------------------------------------

- Veleka Peeples-Dyer appointed to Board as tenth member, filling vacancy from Board size increase.
- She also joins the Audit Committee, replacing Dieter Weinand; receives annual retainers of $45,000 (Board) and $10,000 (Audit).
- Granted nonqualified stock option for 50,400 shares at $18.48 strike, vesting 25% after one year then monthly over 24 months.
- Ms. Peeples-Dyer brings over 24 years of life sciences legal and compliance experience, including executive roles at biopharma companies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737953/000110465923067856/0001104659-23-067856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737953/000110465923067856/tm2317684d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-067856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer